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i.org/1identify patients at risk for dissection, but data on children remain unclear. We retro-
spectively evaluated the aortic diameters of all pediatric BAV patients, identiﬁed through
an echocardiographic database (2005 to 2013). Medical records were reviewed and aortic
diameters re-measured on echocardiographic images at diagnosis and if available on var-
iable mid- and endpoints follow-up. Dilatation (z-score >2) was based on 2 different z-score
equation methods (Gautier/Campens). In 234 of the total 250 BAV patients, aortic di-
ameters were analyzed; median age was 6.1 years (interquartile range 1.7 to 10), of which
63% were male. Aortic coarctation was present in 81 (36%) patients, 23% had a ventricular
septal defect. BAV morphology according to Sievers was as follows: type 0 in 128 patients
(55%), type 1 in 96 (41%), and type 2 in 10 (4%). Ascending aortic (AA) dilatation was
present in 24% (Gautier) and 36% (Campens) at inclusion. Median follow-up was 4.7 years.
The AA was the only location where mean z-scores progressed signiﬁcantly with age: 0.06
(Gautier) and 0.09 (Campens) units per year between ages 5 and 15 years. Associations for
higher AA z-scores at older age were an initial z-score >2 (p <0.001) and aortic valve
stenosis (p <0.05). Neither dissection nor preventive aortic surgery occurred. In conclusion,
only the AA seems at risk for complication, although no aortic complications occurred in
this pediatric BAV cohort. BAV morphology seems associated with larger AA z-scores and
valvular dysfunction.  2017 The Author(s). Published by Elsevier Inc. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). (Am J
Cardiol 2017;-:-e-)Bicuspid aortic valve (BAV) is the most common
congenital heart defect and has considerable morbidity and
mortality.1e3 It occurs isolated or in combination with
additional heart defects and may occur in the context of a
syndrome.1,4e7 In young adults, valve dysfunction requiring
an intervention occurs frequently and valve dysfunction
degree seems associated to BAV morphologic
phenotype.1,4,5,8e11 Aortic dilatation, predisposing for life-
threatening rupture and dissection, is found in half of
adult patients.1,12e14 Dilatation rates and its associations are
well studied in adults,12,13,15,16 but for children these data
are largely unclear.8,10,17e19 In children, the aortic diameter
is typically corrected, mostly for body size area, age, andf Pediatric Cardiology, Amalia Children’s Hospital and
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0.1016/j.amjcard.2017.03.245gender. The advised method is to use z-scores (the number
of standard deviations above or below the expected diam-
eter). Different regression equations for expected aortic
diameter and corresponding z-scores are currently in use,
none of which having emerged as optimal. In the present
study, we retrospectively investigated aortic diameter (z-
score) change during follow-up and its possible associations
in a pediatric cohort with BAV.
Methods
We included all children <18 years diagnosed with a
BAV, who underwent echocardiography between 2005 and
2013 in our center. Echocardiographic studies were per-
formed by trained sonographers using GE Vivid 7, E9, or S6
and assessed in EchoPac PC 113 (GE Healthcare). Correct
diagnosis and BAV morphology were determined by 2 in-
dependent researchers (EV, MS) in parasternal short-axis
view. In 25 inconclusive cases, a third experienced cardi-
ologist (ALD) had decisive judgment. Aortic diameters were
measured if at least 1 echocardiographic study, accompanied
by height and weight data, provided good view of the
ascending aorta (AA) distal to the sinotubular junction
(STJ). Exclusion criterion was valve replacement before
start of the study.
We reviewed medical records for cardiac anomalies,
syndromes, interventions, and valve dysfunction at included
echocardiographies. Lesions presented together as Shone’s
syndrome were scored separately for this study. Valve
morphology was classiﬁed by the number of raphesccess article www.ajconline.org
Figure 1. Sievers classiﬁcation applied on echocardiography (top view).
“Type” represents the number of raphes, the subtype represents the spatial
arrangement. AP¼ anteroposterior orientation; L ¼ left coronary cusp; N¼
noncoronary cusp; R ¼ right coronary cusp.
2 The American Journal of Cardiology (www.ajconline.org)(malformed commissures) and spatial conﬁguration of the
cusps according to a pathological classiﬁcation by Sievers
and Schmidtke,20 modiﬁed for echocardiography (Figure 1).
Aortic valve stenosis (AS) was deﬁned as a peak velocity
(Vmax) >2.5 m/s, as jet velocity is the strongest predictor for
clinical outcome.21 Aortic valve regurgitation was present
when reported mild or more, based on jet evaluation and
descending aortic backﬂow on color Doppler, left ventric-
ular dimensions, and pressure half-time.22 Patients were
scored as having hypertension when they were medically
treated for high blood pressure.
One researcher (RM) measured aortic diameters at the
sinus of valsalva (SOV), STJ, and AA, deﬁned as maximal
diameter between STJ and aortic arch. Up to 3 studies were
included (oldest, latest, and middlemost; 6 months apart).
Measurements were performed in parasternal long-axis view
at end-diastole, leading edge to leading edge, and perpen-
dicular to the long axis of the aorta (Supplementary
Figure 1).23 Averages of 3 measurements, preferably in
various cardiac cycles, were used. Missing height and
weight data were interpolated if growth curves looked stable
and had at least 4 points within 9 months.
Continuous variables are presented as mean (SD) or
median (interquartile range [IQR]) where appropriate, and
categorical variables as frequencies. Differences were
detected with Student’s t, one-way analysis of variance,
Pearson chi-square, Fisher’s exact, or McNemar tests.
Intraclass correlation and Bland-Altman plots assessed
interobserver agreement on aortic measurements between 2
observers in 20 random patients. Aortic diameters were
converted to z-scores using 2 different methods: by Gautier
et al and by Campens et al. Both used the body surface area
formula by Du Bois and both did not include neonates and
toddlers,24,25 although, as representative data on these veryyoung children are lacking, we nevertheless chose to apply
these methods. For this reason, we also performed additional
regression analysis on absolute diameters at ﬁrst examina-
tion. A z-score >2 was considered abnormal. Only Gautier’s
method was used for analysis of aortic growth in various
subgroups. To account for dependency of serial measure-
ments, the mean z-score over time was described with 5th
order polynomials (quintics) constructed from a linear
mixed-effects model, allowing single and serial measure-
ments, unequal intervals, and a random intercept per subject.
A likelihood ratio test assessed differences between sub-
groups. This model only allowed a univariate approach.
p-values <0.05 were considered statistically signiﬁcant.
Analyses were performed in SPSS 20 (IBM Corp.).
Results
Of 11,792 children who underwent echocardiography,
BAV was reported in 286. A total of 36 patients were
excluded from the study because of incorrect diagnosis (n ¼
32), missing images (n ¼ 1) or cardiac surgery distorting
original valve anatomy before 2005 (n ¼ 3). Of the 250
(2.1%) remaining patients, aortic diameters could be
assessed in 234 (Ross procedure after 2005, n ¼ 1; image
storage errors, n ¼ 4; inadequate images, n ¼ 7; no height or
weight data, n ¼ 4), providing 580 studies. Table 1 de-
scribes their baseline characteristics, categorized by valve
morphology. Median age at ﬁrst valve intervention was
0.4 years (IQR 0 to 2.3). Patients with aortic coarctation had
signiﬁcantly lower rates of valve interventions compared
with those without (7% vs 19%, p <0.05).
Interobserver agreement coefﬁcients on aortic measure-
ments were 0.98 (SOV), 0.87 (STJ), and 0.96 (AA). Overall
difference between observers was 0.39 mm (p <0.01;
Supplementary Figures 2 and 3). In 195 subjects, serial
echocardiographic studies were available, with a median
follow-up of 4.7 years (IQR 2.7 to 6.57). All ages were
represented, with a slight overrepresentation of infants
(Supplementary Figure 4). The median age at ﬁrst exami-
nation was 6.1 years (IQR 1.7 to 10). During follow-up, 2
patients deceased (noncardiac death: 1 of hematologic and 1
of severe embryological disease) and 3 others underwent a
Ross procedure for valve dysfunction, whereupon follow-up
ended.
No aortic rupture, dissection, or preventive surgery was
reported during follow-up. Mean z-scores and the preva-
lence of a z-score >2 at ﬁrst examination were highest for
the AA (Table 2), irrespective of the used z-score equa-
tion.24,25 Figure 2 presents the 5th order polynomials best
estimating the mean course of z-scores, with 95% conﬁ-
dence intervals of the estimate. The AA showed highest z-
scores and was the only location demonstrating signiﬁcant
growth between ages 5 and 15 years, for both z-score
equations: 0.67 to 1.24 (Gautier) and 0.45 to 1.29 (Camp-
ens), resulting in mean growth rates of 0.06 and 0.09 z-score
units per year, respectively. Both methods showed no z-
score progression for the SOV. The STJ was signiﬁcantly
greater than normal, but also nonprogressive. Signiﬁcant
differences are observed between both methods of z-score
equation, particularly in the neonatal and toddler ages, with
exceedingly high z-scores for Campens’ equation.
Table 1
Demographics, categorized by Sievers’ valve morphology
Characteristics Total
n ¼ 234
Type 0 Type 1 Type 2
AP LAT RL RN LR:RN
n ¼ 97 (42%) n ¼ 31 (13%) n ¼ 53 (23%) n ¼ 43 (18%) n ¼ 10 (4%)
Growth parameters (mean  SD)
Age (years) 6.4  5.0 6.2  5.5 6.9  5.4 6.4  4.9 6.2  4.2 6.8  3.1
Body Surface Area (m2) 0.8  0.4 0.8  0.5 0.9  0.5 0.8  0.4 0.8  0.4 0.9  0.2
Body Mass Index (kg/m2) 16  3 16  3 16  3 16  3 16  2 15  2
Male sex 63% 59% 52% 70% 65% 100%
Syndrome 11% 14% 7% 13% 7% 0%
Turner 5% † 5% 7% 8% 2% 0%
22q11 deletion 3% 5% 0% 2% 0% 0%
Other z 3% 4% 0% 4% 5% 0%
Cardiac malformations x
Any** 57% 78% 35% 49% 35% 60%
Coarctation of the aorta** 36% 52% 16% 34% 14% 40%
Ventricular septal defect* 23% 33% 19% 19% 7% 30%
Patent ductus arteriosus 15% 23% 7% 9% 9% 10%
Atrial septal defect 9% 12% 7% 8% 9% 0%
Hypoplastic aortic arch 9% 12% 10% 4% 2% 20%
Other* z 33% 44% 19% 26% 23% 30%
Systemic hypertension k 5% 5% 7% 8% 0% 0%
Aortic valve dysfunction k
Any** 57% 37% 74% 55% 81% 100%
Aortic valve stenosis** 40% 15% 61% 34% 72% 100%
Aortic valve regurgitation** 48% 30% 61% 47% 74% 70%
Aortic valve intervention** 16% 6% 23% 15% 35% 10%
2nd 5% . . . . .
3rd, 4th, 5th 0.4% . . . . .
Ascending aortic intervention 0% . . . . .
Aortic arch intervention** 33% 50% 13% 30% 14% 40%
Signiﬁcance of association between presented characteristic and BAV morphologic phenotype: *p <0.05, **p <0.001.
AP ¼ anterior-posterior orientation; LAT ¼ lateral orientation; RL ¼ right-left coronary cusp fusion; RN ¼ right-noncoronary cusp fusion; LR:RN ¼ left-
right and right-noncoronary cusp fusion.
† 13% of female subjects.
z Speciﬁcation in Supplementary Table 1.
x One patient can have several malformations.
k Considered present if seen in at least one of the echocardiographic studies.
Congenital Heart Disease/Aortic Diameters in Pediatric BAV 3Figure 3 shows a regression analysis of the absolute AA
diameters at ﬁrst examination of all patients and of 11 pa-
tients with isolated and, during follow-up, normally func-
tioning BAV, including a correction for body surface area.
Absolute AA diameter growth was 1.04 mm/year. We did
not observe clinically relevant differences in subjects with
aortic coarctation or valve dysfunction.
Figure 4 shows that an AA z-score >2 at inclusion was
associated with a higher AA z-score at older age, compared
with patients with an initial z-score<2 (p<0.001). However,
the z-score progression rate (Dz/Dt) was only minimally
different between both groups and thus larger AA diameter
was not associated with “faster” AA growth. Presence of AS
also resulted in signiﬁcantly higher AA z-scores (p <0.05),
but was associated to type 2 valve morphology (Table 1).
However, the latter was present in only 10 patients. The
presence of an initial z-score >2 was not associated to the
presence of AS. Comparing patients with versus without
aortic regurgitation, aortic arch and valve interventions, and
speciﬁcally a history of coarctation did not result in signiﬁ-
cant differences in estimated z-score course.For the SOV, a z-score >2 at inclusion (p <0.001), male
gender (p <0.01), Sievers’ type 2 (p <0.01), syndromes (p
<0.001), and absence of AS (p <0.05) were associated with
higher z-scores (Supplementary Figure 5). However, these
factors were not independent: subjects with a syndrome
more often had an initial z-score >2 (23% vs 6%, p <0.05)
and less often had AS (28% vs 60%, p <0.01). Subjects
with AS less often had an initial z-score >2 (4% vs 13%, p
<0.05). Higher STJ z-scores were observed in syndromes (p
<0.05), subjects with an initial z-score >2 (p <0.001), and
right-non coronary cusp fusion subtype within Sievers’ type
1 valve morphology (p <0.01; Supplementary Figure 6), but
again, they were nonprogressive.
Discussion
In this large population of children with BAV, we
observed no rupture, dissection, or need for preventive
aortic surgery. Only the AA z-score progressed with time,
showing that the main emphasis on follow-up should lie on
the aortic diameters at this location. An initial z-score >2
Table 2
Mean z-scores and prevalence of a z-score >2 at ﬁrst echocardiography
(n ¼ 234, median age ¼ 6.1 years)
Gautier’s
equation
Campens’
equation
p-value
Z-score (mean SD)
Sinus of Valsalva -0.2  1.5 0.6  1.5 z <0.001
Sinotubular junction 0.3  1.8 † - -
Ascending aorta 0.8  1.7 z 1.4  2.2 z <0.001
Z-score >2 (% SE)
Sinus of Valsalva 8  2 15  2 <0.001*
Sinotubular junction 15  2 - -
Ascending aorta 24  3 36  3 <0.001*
Signiﬁcance compared with normal population (mean z-score ¼ 0): †p
<0.01; zp <0.001.
Campens did not provide an equation for the sinotubular junction.
* McNemar test.
Figure 2. Estimated mean z-scores plotted as a quintic function against age,
based on 2 methods of z-score equation. Error bars denote half 95% con-
ﬁdence intervals of the estimate. Functions are displayed in Supplementary
Table 2, for reproducibility reasons. AA ¼ ascending aorta; SOV ¼ sinus of
Valsalva; STJ ¼ sinotubular junction.
4 The American Journal of Cardiology (www.ajconline.org)and presence of AS were clinical markers for higher z-scores
in early adulthood, but z-score progression was not faster.
Indeed, aortic pathology in the context of BAV seems not a
clinical problem in childhood. Previous studies compared
contributing factors using numerical growth rates. This is
the ﬁrst study providing a visualized comparison of aortic
diameter growth in children with a BAV.8,10,17e19
As expected, BAV was common in our pediatric cardi-
ology department and clearly associated with valve- and
nonevalve-related morbidity such as coarctation of the
aorta,2,26 but also with other anomalies such as ventricular
septal defects and patent ductus arteriosus, for which only
putative associations were mentioned.5e7,27e29 Awareness
and echocardiographic screening for other anomalies in
clinical practice is mandatory. Similar to Fernandes et al,9
valve interventions occurred in a minority and mainly
early in life, typically for aortic stenosis. Most importantly,
no intervention for aortic dilatation was needed and no
complications of aortic dilatation occurred. However, some
follow-up seems warranted as we do not want to miss the
individual patient with rapid increase in diameter. For the
patient with isolated, normally functioning BAV, we sug-
gest to perform echocardiography every 5e10 years.The AA shows the largest relative diameter and clearly
grows faster than can be expected based on body growth
and/or age. No signiﬁcant differences in absolute AA
diameter were observed between patients with isolated BAV
and BAV patients with associated lesions or valve
dysfunction. However, the isolated BAV group was only
small. Although patients with an initial z-score >2 and
patients with AS had a higher initial z-score, they all had
similar AA growth, which makes AA diameter growth
predictable. The progression of 0.06 to 0.09 z-score units
per year was notably similar to literature that likewise used
z-scores,8,10 as was absolute aortic diameter growth.17 Fer-
nandes et al8 earlier concluded that young patients initially
presenting with higher z-scores seem to be at highest risk for
aortic dilatation at later age, and this seems valid for all
locations. It seems logical that only the AA is at risk for
dilatation-related complications, as it is the only location
showing z-score progression, but whether these patients
indeed have an elevated need to undergo (preventive) aortic
surgery at later age is not well studied. We propose regular
follow-up for patients entering young adulthood to over-
come this gap in knowledge.
Earlier studies suggested protective effects of a coarcta-
tion history on AA z-score progression, but we could not
conﬁrm this ﬁnding.8,13,15 Also, aortic regurgitation and
aortic or valvular interventions were not associated with
aortic size. Previous studies reported conﬂicting data on the
increase of aortic dimensions at the level of the
SOV.8,10,17e19 We found no z-score progression at this
level. The clinical relevance of having an underlying syn-
drome on STJ diameters remains unclear, mainly because of
the heterogeneity of this group.
It is suggested that in adult cohorts, BAV morphology is
associated with valve dysfunction and complications.3e6
Our study conﬁrms this in a pediatric cohort. Valve
morphology should be determined at young age, for which
in our opinion Sievers’ classiﬁcation is applicable. Distri-
bution of BAV morphology differed from Sievers’ original
study, possibly because of differences in age category.20
Comparing studies that included BAV morphology is
challenging because of a large variety in classiﬁcations.
Many studies applied morphologic classiﬁcation named af-
ter localization of 1 supposed fusion line (right-left, right-
non and left-non coronary cusp fusion), whereas Sievers’
classiﬁcation also allows 0 and 2 fusion lines.5,8,9 Given the
visual similarities between type 0 anteroposterior orientation
and type 1 right-left coronary cusp fusion and between type
0 lateral orientation and type 1 right-left or left-non coronary
cusp fusion (Figure 1), distribution of morphology, valve
dysfunction, and interventions were notably similar to the
literature.5,9
z-score equation methods by Gautier et al and Campens
et al regrettably are not designed for use in patients below
2 years, causing z-scores in these subjects to be only based
on extrapolated data and difﬁcult to interpret.24,25 Both
methods provide clearly different results in this age group,
with Campens’ method appearing the least accurate. For this
reason, we calculated the annual z-score progression in
children between 5 and 15 years. As we clinically found
children presenting with AA z-scores >2 to have larger AAs
in adolescence, we urge the need for z-score validation in
Figure 3. Regression analysis of absolute AA diameters in mm at ﬁrst echocardiographic examination of all patients, including a correction for body surface
area, and of 11 patients with isolated and, during follow-up, normal functioning BAV. Dotted lines denote 95% prediction intervals. AA ¼ ascending aorta;
BSA ¼ body surface area.
Figure 4. Ascending aortic z-scores plotted against age, broken down by
their signiﬁcant associations: z-score at ﬁrst examination (p <0.001) and
aortic valve stenosis (p <0.05).
Congenital Heart Disease/Aortic Diameters in Pediatric BAV 5cohorts with sufﬁcient representation of neonates and tod-
dlers, for the clinician to be aware of the expected growth.
Instead of using the z-score, we propose to use Figure 3 to
evaluate whether a speciﬁc AA diameter is abnormal for a
child with a BAV and possibly associated with complica-
tions later in life. This could be of beneﬁt especially in
patients younger than 5 years of age as the z-score has clear
limitations here. Patients with an AA diameter above the
95% prediction interval of our BAV cohort should therefore
probably be controlled more frequently.
All limitations of a retrospective study apply. We studied
subjects in our tertiary center, introducing a selection bias.
Two-dimensional echocardiography might not represent the
3-dimensional aortic shape and might have been subject to
technical improvement during the study. We nonetheless
believe in the reproducibility of this study with high inter-
observer agreement and observed differences within re-
ported measurement variability.23 Echocardiography is still
the primary investigation of choice for diagnosis and follow-
up of children with a BAV, making our results applicable to
most clinical situations. Our predictions lack external vali-
dation and we hope other research groups will provide this
in the near future. The elementary shape of a 5th order
polynomial might inﬂuence results in the extreme ages,
although accuracy is suggested by the population size.Acknowledgment: We sincerely thank T. de Haan (statis-
tics) and C. de Korte and G. Weijers (data acquisition).
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